NCIMMUNE LEADING EARLY CANCER DETECTION

Results, Reports & Presentations

Oncimmune Holdings PLC was admitted to trading on the Alternative Investment Market (“AIM”) of the London Stock Exchange on Wednesday 18th May 2016. When the Company publishes financial reports, in keeping with its regulatory obligations, these documents will be available here.

Date Title Link/PDF
February 10 Interim Results For the half year ended 30 November 2016 Interim Results
November 7 Annual Report For the year ended 31 May 2016 Annual Report
Date Title Link/PDF
Date Title Link/PDF
February 10 Interim Results Presentation For the half year ended 30 November 2016 Interim Results Presentation

PLEASE READ THE FOLLOWING STATEMENT CAREFULLY

Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept